Literature DB >> 11566474

Tissue sealing.

T Morikawa1.   

Abstract

The tissue adhesive property of fibrinogen was first described 60 years ago. However, it was not until the availability of concentrated plasma fibrinogen and bovine thrombin that the use of fibrin sealants in surgical practice became widespread. Today, fibrin sealants are used for tissue sealing across a range of surgical procedures, including cardiothoracic, gastrointestinal, neurosurgery, and vascular surgery. Tissue sealing with fibrin sealant reduces perioperative hemorrhage and controls blood loss from cut surfaces of tissues that are difficult to suture. The use of fibrin sealants can also reduce perioperative and postoperative complications by reducing fluid leakage, air leakage, and by preventing fistulae formation. Fibrin sealants have a unique physiologic action, and the resulting fibrin clot is fully degraded by the body's natural wound healing process. The range of surgeries and types of procedure that incorporate the use of fibrin sealants in tissue sealing is expanding. As commercially prepared fibrin sealants become more widely available, the number of patients and surgeons benefiting from improved surgical outcomes is also set to increase. This article reviews the areas of surgery within which fibrin sealants are currently used to assist tissue sealing and highlights the improved surgical outcomes, such as reduced blood loss, operative time, and postoperative complications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566474     DOI: 10.1016/s0002-9610(01)00774-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Shuhei Ueda; Toshiyuki Fujii; Hitoshi Kohno; Naofumi Nagasue
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

2.  An evaluation of the surgical morbidity of polyglycolic acid felt in pulmonary resections.

Authors:  Toru Nakamura; Kazuya Suzuki; Takahiro Mochizuki; Yasuhisa Ohde; Hiroshi Kobayashi; Futoru Toyoda
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

3.  Use of fibrin sealants for the localized, controlled release of cefazolin.

Authors:  Stephen Tredwell; John K Jackson; Donald Hamilton; Vivian Lee; Helen M Burt
Journal:  Can J Surg       Date:  2006-10       Impact factor: 2.089

4.  Comparison of octyl-2-cyanoacrylate and conventional sutures in facial skin closure.

Authors:  D M Shivamurthy; Sourav Singh; Sasidhar Reddy
Journal:  Natl J Maxillofac Surg       Date:  2010-01

Review 5.  Fibrin as a Multipurpose Physiological Platform for Bone Tissue Engineering and Targeted Delivery of Bioactive Compounds.

Authors:  Bruno Bujoli; Jean-Claude Scimeca; Elise Verron
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.